EP1660111A1 - Kollagenhydrolysat - Google Patents
KollagenhydrolysatInfo
- Publication number
- EP1660111A1 EP1660111A1 EP04763893A EP04763893A EP1660111A1 EP 1660111 A1 EP1660111 A1 EP 1660111A1 EP 04763893 A EP04763893 A EP 04763893A EP 04763893 A EP04763893 A EP 04763893A EP 1660111 A1 EP1660111 A1 EP 1660111A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- collagen hydrolyzate
- infants
- collagen
- hydrolyzate according
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/28—Substances of animal origin, e.g. gelatin or collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Definitions
- the invention relates to novel therapeutic applications of collagen hydrolyzate as a nutritional supplement in infants.
- Collagen hydrolyzate is a denatured and partially hydrolyzed protein, obtained from collagenous substances from vertebrates, especially mammals, poultry or fish. Collagen hydrolysis produces peptides with different structures and different biological effects. Collagen hydrolyzate contains approximately twice the proportion of the amino acids lysine, glycine and glutamine as the average of the dietary protein. Collagen hydrolyzate is also rich in the amino acids proline and hydroxyproiin. No other concentration of hydroxyproiin has been detected in any other food. The amino acids mentioned are indispensable for the construction of human collagen, i.e. for connective tissue metabolism, especially bone and cartilage metabolism.
- Gelatin-containing preparations have found their way into the treatment of degenerative joint diseases, as has hydrolyzed collagen in the treatment of osteoporosis in adults (cf. US Pat. No. 5,948,766 A).
- the use of the hydrolyzed gelatin as a carrier means that the instant tea has a very low nutritional value, so that additional nutrients can be avoided unintentionally and in an uncontrolled manner.
- gelatin hydrolyzate in combination with another protein hydrolyzate, in particular whey hydrolyzate, was already known from DE 24 05 589 C3.
- the gelatin is used there as an aid in the recovery of the whey hydrolyzate and avoids the formation of degradation products with an intense bitter taste in the hydrolysis reaction. It also emphasizes that gelatin hydrolyzate alone is disadvantageous as a food because it has only a low content of essential amino acids.
- a protein from the group of whey, milk, soybean, corn, potato, wheat, oil, nut kernel, sunflower seed and egg proteins is used there in the presence of gelatin or gelatin degradation products , These breakdown products are then also recommended as a food additive. Children's nutrition and dietetic foods are also mentioned there. The only function of gelatin is to avoid bitter substances as breakdown products.
- Hydrolyzed collagen and hydrolyzed gelatin are essentially the same.
- hydrolyzed gelatin only the intermediate step of obtaining and isolating gelatin was interposed before the polypeptide chains are broken down to molecular weights or chain lengths corresponding to those of the hydrolyzed collagen, also called collagen hydrolyzate, by means of further hydrolysis.
- Collagen hydrolyzate and gelatin hydrolyzate are therefore often used interchangeably.
- collagen hydrolyzate which has been produced in an enzymatic proteolytic process.
- the inventors were able to demonstrate in a study that the addition of collagen hydrolyzate to baby food manifests itself in an increased, improved general well-being in infants and is very specific. fish reduces the restlessness of the infants. It was also surprisingly found that the addition of collagen hydrolyzate to the infant formula results in a suppression of flatulence in the infant. It was also found that the spitting of infants after ingestion when collagen hydrolyzate was added to the infant formula was significantly reduced.
- collagen hydrolyzate is recommended to support rickets treatment and / or prophylaxis in infants, in particular in combination with vitamin D.
- Collagen hydrolyzates obtained by enzymatic proteolytic methods are particularly preferred. With this type of collagen hydrolyzate, the amount of bitter substances is minimal.
- collagen hydrolyzate for use as a nutritional supplement for baby food is its cold solubility in water, i.e. the solubility to a clear solution at 23 ° C. This has particular advantages for use and administration with the food to infants.
- the hip ultrasound examination was carried out in a standardized manner in a storage tray according to the guidelines of Graf [11,11].
- a 7.5 MHz linear scan (Ultramark 11+) was used as the transducer, 2 images each were frozen and then printed out and evaluated on a 2: 1 scale using a video printer.
- Analogue to the criteria according to Graf alpha and beta angles were determined as well as the following descriptive features: bony shape, bony oriel, socket roof, cartilaginous roofing, femoral head position and femoral core.
- the hip type was determined from this.
- the time of the sonographically detectable occurrence of ossification of the femoral core was included
- FIGS 3 and 4 illustrate the sonographic finding
- the proposed form of application was to dissolve the powder in water or milk and to administer vitamin D prophylaxis (500 IU (vitamin D fluorine)) simultaneously orally using a pipette.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Otolaryngology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10339180A DE10339180A1 (de) | 2003-08-21 | 2003-08-21 | Kollagenhydrolysat |
PCT/EP2004/008864 WO2005021027A1 (de) | 2003-08-21 | 2004-08-06 | Kollagenhydrolysat |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1660111A1 true EP1660111A1 (de) | 2006-05-31 |
Family
ID=34202040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04763893A Withdrawn EP1660111A1 (de) | 2003-08-21 | 2004-08-06 | Kollagenhydrolysat |
Country Status (14)
Country | Link |
---|---|
US (1) | US20060275345A1 (es) |
EP (1) | EP1660111A1 (es) |
JP (1) | JP2007502607A (es) |
AU (1) | AU2004267925A1 (es) |
BR (1) | BRPI0413799A (es) |
CA (1) | CA2536968A1 (es) |
CR (1) | CR8240A (es) |
DE (1) | DE10339180A1 (es) |
EA (1) | EA011482B1 (es) |
EC (1) | ECSP066387A (es) |
MX (1) | MXPA06001968A (es) |
NO (1) | NO20061263L (es) |
WO (1) | WO2005021027A1 (es) |
ZA (1) | ZA200601487B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2947353A1 (en) * | 2006-06-13 | 2007-12-21 | Helix Biomedix Inc. | Peptide fragments for inducing synthesis of extracellular matrix proteins |
ES2298071B1 (es) * | 2006-10-25 | 2009-07-28 | Masterfarm,S.L. | Hidrolizado enzimatico de colageno y procedimiento de obtencion. |
DE102007002295A1 (de) * | 2007-01-09 | 2008-07-10 | Gelita Ag | Nahrungsmittelprodukt auf Proteinbasis und Verfahren zur Herstellung |
JP2008266222A (ja) * | 2007-04-20 | 2008-11-06 | Nippi:Kk | 強皮症に合併する指先の潰瘍に対するコラーゲンペプチドの作用 |
JP2011136945A (ja) * | 2009-12-28 | 2011-07-14 | Lotte Co Ltd | 皮脂分泌抑制剤及びそれを用いた飲食物及び組成物 |
ES2791448T3 (es) | 2013-01-23 | 2020-11-04 | Bottled Science Ltd | Composición de bebida para mejorar la piel |
DE102014108502A1 (de) * | 2014-06-17 | 2015-12-17 | Gelita Ag | Zusammensetzung in Form von kompaktierten Partikeln und deren Verwendung |
WO2016102275A1 (en) * | 2014-12-22 | 2016-06-30 | Nestec S.A. | Entrapment of bitter peptides by a gel comprising gelatin |
DE102019202606A1 (de) * | 2018-11-06 | 2020-05-07 | Gelita Ag | Rekombinante Herstellung eines Kollagenpeptidpräparates und dessen Verwendung |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1227534A (es) * | 1967-08-31 | 1971-04-07 | ||
DE2405589C3 (de) * | 1974-02-06 | 1980-08-07 | Agfa-Gevaert Ag, 5090 Leverkusen | Verfahren zur Herstellung leicht benetzbarer, wasserlöslicher natürlicher Eiweißprodukte |
DE3237077A1 (de) * | 1982-10-07 | 1984-04-12 | Krüger GmbH & Co KG, 5060 Bergisch Gladbach | Instant-tees und verfahren zu ihrer herstellung |
US4732773A (en) * | 1982-07-17 | 1988-03-22 | Kruger Gmbh & Co. Kg | Instant beverage and instant tea |
US5866357A (en) * | 1990-03-09 | 1999-02-02 | Novo Nordisk A/S | Method for hydrolyzing proteins with gluyasp specific protease |
EP0777491B1 (de) * | 1994-08-23 | 2004-11-17 | Deutsche Gelatine-Fabriken Stoess AG | Verwendung von geschmacksneutralem, hydrolysiertem kollagen und mittel enthaltend dasselbe |
JP4609807B2 (ja) * | 1996-03-28 | 2011-01-12 | 雪印乳業株式会社 | 骨強化用医薬、飲食品及び飼料 |
US6248378B1 (en) * | 1998-12-16 | 2001-06-19 | Universidad De Sevilla | Enhanced food products |
US6011038A (en) * | 1997-09-05 | 2000-01-04 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
RU2133097C1 (ru) * | 1997-11-12 | 1999-07-20 | Закрытое акционерное общество "Фермент плюс" | Способ получения кормовой добавки "витапептид", кормовая добавка "витапептид" |
JP3881453B2 (ja) * | 1998-05-14 | 2007-02-14 | 新田ゼラチン株式会社 | カルシウム吸収促進剤およびその製造方法 |
JP2000083695A (ja) * | 1998-09-16 | 2000-03-28 | Ajinomoto Co Inc | 低苦味ペプチドの製造法 |
JP2001031586A (ja) * | 1999-07-14 | 2001-02-06 | Sunstar Inc | 動脈硬化症及び動脈硬化症に起因する疾患の予防又は治療組成物 |
US6383534B1 (en) * | 2000-01-18 | 2002-05-07 | Lorin Dyrr | Mineral water composition |
US6365218B1 (en) * | 2000-02-04 | 2002-04-02 | Abbott Laboratories | Pediatric formula and methods for providing nutrition and improving tolerance |
-
2003
- 2003-08-21 DE DE10339180A patent/DE10339180A1/de not_active Withdrawn
-
2004
- 2004-08-06 BR BRPI0413799-0A patent/BRPI0413799A/pt not_active IP Right Cessation
- 2004-08-06 JP JP2006523564A patent/JP2007502607A/ja active Pending
- 2004-08-06 CA CA002536968A patent/CA2536968A1/en not_active Abandoned
- 2004-08-06 MX MXPA06001968A patent/MXPA06001968A/es unknown
- 2004-08-06 AU AU2004267925A patent/AU2004267925A1/en not_active Abandoned
- 2004-08-06 WO PCT/EP2004/008864 patent/WO2005021027A1/de active Application Filing
- 2004-08-06 EA EA200600382A patent/EA011482B1/ru not_active IP Right Cessation
- 2004-08-06 EP EP04763893A patent/EP1660111A1/de not_active Withdrawn
-
2006
- 2006-02-17 US US11/356,415 patent/US20060275345A1/en not_active Abandoned
- 2006-02-20 ZA ZA200601487A patent/ZA200601487B/en unknown
- 2006-02-20 CR CR8240A patent/CR8240A/es not_active Application Discontinuation
- 2006-02-21 EC EC2006006387A patent/ECSP066387A/es unknown
- 2006-03-20 NO NO20061263A patent/NO20061263L/no not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO2005021027A1 * |
Also Published As
Publication number | Publication date |
---|---|
DE10339180A1 (de) | 2005-03-24 |
NO20061263L (no) | 2006-03-20 |
JP2007502607A (ja) | 2007-02-15 |
ZA200601487B (en) | 2007-04-25 |
EA011482B1 (ru) | 2009-04-28 |
AU2004267925A1 (en) | 2005-03-10 |
CR8240A (es) | 2006-10-18 |
ECSP066387A (es) | 2006-08-30 |
CA2536968A1 (en) | 2005-03-10 |
US20060275345A1 (en) | 2006-12-07 |
BRPI0413799A (pt) | 2006-10-31 |
MXPA06001968A (es) | 2006-08-31 |
EA200600382A1 (ru) | 2006-10-27 |
WO2005021027A1 (de) | 2005-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69727332T2 (de) | Zubereitungen enthaltend Kollagen, Vitamin D3 und Kalzium zur Verstärkung des Knochens | |
JP5959137B2 (ja) | 乳由来リン脂質を含有する乳幼児脳発達促進剤及びそれを含有する食品組成物 | |
CN107343657A (zh) | 生酮饮食配方粉 | |
US20200108040A1 (en) | Agent for improving brain function and agent for preventing or treating cognitive impairment | |
KR101952078B1 (ko) | 체중 조절용 식품 조성물 | |
US20060275345A1 (en) | Collagen hydrolysate | |
DE2755709A1 (de) | Verfahren zum anheben des metallgehalts in gewebe | |
RU2529154C1 (ru) | Полуфабрикат мясорастительный рубленый обогащенный | |
DE69330595T2 (de) | Zubereitungen und Nahrungsmittel enthaltend Mineralien und Poly-gamma-Glutaminsäure | |
EP2545789A1 (de) | Proteinhaltige Nahrungsmittelzusammensetzung | |
EP2996710B1 (de) | Wirkstoff zur behandlung von sarkopenie | |
JP6265335B2 (ja) | 骨密度増加剤、破骨細胞活性抑制剤及び骨リモデリング改善剤 | |
EP0028374B1 (de) | Diätmittel, das zur Verringerung des Körpergewichts und Senkung des Serumlipidspiegels geeignet ist, und Verfahren zu seiner Herstellung | |
DE69101847T2 (de) | Zubereitung für die Verhütung oder die Behandlung von Hypertriglyceridämie. | |
DE68912536T2 (de) | Flüssiges Nahrungsmittel zur Proteinzuführung. | |
DE69522723T2 (de) | Antiallergisches Mittel und Nährstoffzusammensetzung, die Glutamin enthalten | |
JP2011063552A (ja) | 身体活動促進剤 | |
JP6071988B2 (ja) | 身体活動促進剤 | |
DE69418254T2 (de) | Calcium enthaltende Zusammensetzung | |
WO2010119804A1 (ja) | 抗精神疲労剤 | |
JPH10191933A (ja) | 亜鉛高含有乳清ミネラル | |
JP7220838B2 (ja) | 経口組成物 | |
JP2022069365A (ja) | 成長ホルモン分泌促進用食品組成物 | |
DE69723417T2 (de) | Propolis Extrakt mit verbesserter Wasserlöslichkeit | |
JP2021065154A (ja) | 咀嚼促進及び唾液分泌促進高蛋白食品組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060216 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20080114 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20101202 |